Myriad Genetics Ownership | Who Owns Myriad Genetics?


OverviewForecastRevenueFinancialsChartTranscripts

Myriad Genetics Ownership Summary


Myriad Genetics is owned by 227.46% institutional investors, 3.26% insiders. Orbimed advisors is the largest institutional shareholder, holding 133.98% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMyriad Genetics227.46%3.26%-130.72%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryDiagnostics & Research Stocks50.92%10.77%38.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors125.00M133.98%$122.88M
Blackrock15.15M18.54%$370.59M
Blackrock funding, inc. /de8.89M9.53%$40.00M
Vanguard group8.23M8.84%$50.59M
Millennium management6.67M7.15%$30.01M
Glenview capital management5.41M5.80%$24.35M
D. e. shaw4.50M4.82%$20.25M
State street4.42M4.74%$19.91M
Morgan stanley3.17M3.40%$14.26M
Bank of america corp /de/2.71M3.31%$66.18M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Amh equity400.00K3.60%$2.89M
Orbimed advisors125.00M2.45%$122.88M
Camber capital management lp2.00M1.00%$10.62M
Glenview capital management5.41M0.61%$24.35M
Anson funds management lp504.38K0.33%$3.65M
Vestal point capital, lp1.65M0.21%$7.42M
Gsa capital partners llp339.90K0.10%$1.53M
Y-intercept (hong kong)654.22K0.06%$2.94M
Headlands105.41K0.05%$474.36K
Aimz investment advisors37.21K0.05%$167.44K

Top Buyers

HolderShares% AssetsChange
Orbimed advisors125.00M2.45%125.00M
Acadian asset management2.31M0.01%1.32M
Hrt financial lp1.79M0.02%1.32M
Jane street group1.20M0.00%1.15M
Marshall wace, llp1.10M0.00%1.08M

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de8.89M0.00%-6.41M
Wellington management group llp---4.59M
Earnest partners---3.98M
Artisan partners limited partnership---2.28M
Loomis sayles & co l p---2.19M

New Positions

HolderShares% AssetsChangeValue
Orbimed advisors125.00M2.45%125.00M$122.88M
Vanguard fiduciary trust615.76K0.00%615.76K$2.77M
Moore capital management, lp218.40K0.02%218.40K$982.79K
Arrowstreet capital, limited partnership204.61K0.00%204.61K$920.74K
Vanguard global advisers183.37K0.00%183.37K$825.16K

Sold Out

HolderChange
Cnb bank-1.00
Global financial private client-3.00
Jfs wealth advisors-3.00
Mendota financial group-3.00
Mather group, llc.-3.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026198-10.00%212,223,284130.12%2272.32%104-10.34%66-10.81%
Dec 31, 202563-71.49%13,263,036-85.02%140.16%30-74.36%21-70.42%
Sep 30, 202579-62.74%17,328,183-77.55%180.27%39-69.29%25-52.83%
Jun 30, 2025218-5.63%90,330,011-3.80%970.92%1308.33%52-32.47%
Mar 31, 20252303.60%93,858,1281.60%1031.00%119-1.65%774.05%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.70M6.09%-224.78K
Vanguard Explorer Inv3.10M3.40%-190.91K
Vanguard Total Stock Mkt Idx Inv2.78M2.97%-
Vanguard US Total Market Shares ETF2.70M2.96%2.75K
State Street® SPDR® S&P® Biotech ETF2.35M2.49%-24.25K
iShares Russell 2000 ETF2.17M2.30%18.28K
Artisan International Small-Mid Investor1.56M1.70%-281.57K
Artisan Non-U.S. Small-Mid Growth Comp1.56M1.70%-281.57K
EARNEST Partners Smid Cap Core Founders1.40M1.52%-970.66K
SPDR® S&P Biotech ETF1.38M1.48%3.08K

Recent Insider Transactions


DateNameRoleActivityValue
May 14, 2026Bisaro Paul-Buy$27.64K
Mar 09, 2026Raha Samraat S. President and CEOBuy$199.84K
Feb 27, 2026Phanstiel S. Louise-Buy$223.73K
Feb 26, 2026Phanstiel S. Louise-Buy$242.10K
Feb 25, 2026Phanstiel S. Louise-Buy$28.89K

Insider Transactions Trends


DateBuySell
2026 Q21-
2026 Q14-
2025 Q4--
2025 Q3--
2025 Q2--

MYGN Ownership FAQ


Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 227.46%, followed by 3.26% insiders and -130.72% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 50.92%, which Myriad Genetics exceeds.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Orbimed advisors (125M shares, 133.98%), Blackrock (15.15M shares, 18.54%), and Blackrock funding, inc. /de (8.89M shares, 9.53%). Together, they hold 162.04% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Amh equity is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 3.60% of its assets in 400K Myriad Genetics shares, valued at 2.89M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 6.09% of its total shares outstanding invested in 5.7M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools